References
- Oncaspar (pegaspargase) [package insert]. U.S. Food and Drug Administration website. 2019. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/103411s5126lbl.pdf.
- Truelove E, Fielding AK, Hunt BJ. The coagulopathy and thrombotic risk associated with L-asparaginase treatment in adults with acute lymphoblastic leukaemia. Leukemia. 2013;27(3):553–559.
- Goyal G, Bhatt VR. L-asparaginase and venous thromboembolism in acute lymphocytic leukemia. Future Oncol. 2015;11(17):2459–2470.
- Stock W, Douer D, DeAngelo DJ, et al. Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel. Leuk Lymphoma. 2011;52(12):2237–2253.
- Grace RF, Dahlberg SE, Neuberg D, et al. The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber cancer institute consortium protocols. Br J Haematol. 2011;152(4):452–459.
- Caruso V, Iacoviello L, Di Castelnuovo A, et al. Thrombotic complications in childhood acute lymphoblastic leukemia: a Meta-analysis of 17 prospective studies comprising 1752 pediatric patients. Blood. 2006;108(7):2216–2222.
- Qureshi A, Mitchell C, Richards S, et al. Asparaginase-related venous thrombosis in UKALL 2003- re-exposure to asparaginase is feasible and safe. Br J Haematol. 2010;149(3):410–413.
- Couturier M-A, Huguet F, Chevallier P, et al. Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: the GRAALL experience. Am J Hematol. 2015;90(11):986–991.
- Siegel SE, Stock W, Johnson RH, et al. Pediatric-Inspired treatment regimens for adolescents and young adults with Philadelphia Chromosome-Negative acute lymphoblastic leukemia: a review. JAMA Oncol. 2018;4(5):725–734.
- National Comprehensive Cancer Network. Acute lymphoblastic leuekemia (Version 2.2021). 2021. https://www.nccn.org/professionals/physician_gls/pdf/all.pdf
- Freyer CW, Carulli A, Ganetsky A, et al. Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementation. Leuk Lymphoma. 2020;61(9):2200–2207.
- Barreto JN, McCullough KB, Peskey CS, et al. Safety and feasibility of lower antithrombin replacement targets in adult patients with hematological malignancies receiving asparaginase therapy < sup/>. Leuk Lymphoma. 2017;58(11):2588–2597.
- Chen J, Ngo D, Aldoss I, et al. Antithrombin supplementation did not impact the incidence of pegylated asparaginase-induced venous thromboembolism in adults with acute lymphoblastic leukemia. Leuk Lymphoma. 2019;60(5):1187–1192.
- George G, Rezazadeh A, Zook F, et al. Reducing venous thrombosis with antithrombin supplementation in patients undergoing treatment for ALL with peg-asparaginase-A real world study. Leuk Res. 2020;94:106368.
- Arya RC, Wander G, Gupta P. Blood component therapy: which, when and how much. J Anaesthesiol Clin Pharmacol. 2011;27(2):278–284.
- Franchini M, Lippi G. Fibrinogen replacement therapy: a critical review of the literature. Blood Transfus. 2012;10(1):23–27.
- Rebulla P, Finazzi G, Marangoni F, et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie ematologiche maligne dell'Adulto. N Engl J Med. 1997;337(26):1870–1875.
- Rank CU, Toft N, Tuckuviene R, et al. Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years. Blood. 2018;131(22):2475–2484.
- Underwood B, et al. Incidence of venous thrombosis after peg-asparaginase in adolescent and young adults with acute lymphoblastic leukemia. Int J Hematol Oncol. 2020;9(3):IJH28.
- Khawar H, et al. Fresh frozen plasma (FFP). In: StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2021, StatPearls Publishing LLC.; 2021, https://www.ncbi.nlm.nih.gov/books/NBK431128/.
- Nascimento B, Callum J, Rubenfeld G, et al. Clinical review: fresh frozen plasma in massive bleedings - more questions than answers. Crit Care. 2010;14(1):202.
- Yang G, Staercke CD, Hooper WC. The effects of obesity on venous thromboembolism: a review. Open J Prev Med. 2012;2(4):499–509.
- Thrombate III. In: Redbook [database on the internet]. Greenwood Village (CO): IBM Corporation; 2021.
- Orvain C, Balsat M, Tavernier E, et al. Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 study. Blood. 2020;136(3):328–338.